Читать книгу Cosmeceuticals - Группа авторов - Страница 31

1Bos JD, Meinardi MM: The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol 2000;9:165–169.

2Naik A, Kalia YN, Guy RH: Transdermal drug delivery: overcoming the skin’s barrier function. Pharm Sci Technolo Today 2000;3:318–326.

3Paudel KS, et al: Challenges and opportunities in dermal/transdermal delivery. Ther Deliv 2010;1:109–131.

4Zaleski-Larsen LA, Fabi SG: Laser-assisted drug delivery. Dermatol Surg 2016;42:919–931.

5Feingold KR: Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis. J Lipid Res 2007;48:2531–2546.

6Nino M, Calabro G, Santoianni P: Topical delivery of active principles: the field of dermatological research. Dermatol Online J 2010;16:4.

7Liu X, et al: Hair follicles contribute significantly to penetration through human skin only at times soon after application as a solvent deposited solid in man. Br J Clin Pharmacol 2011;72:768–774.

8Patel N, et al: Application of design of experiments for formulation development and mechanistic evaluation of iontophoretic tacrine hydrochloride delivery. Drug Dev Ind Pharm 2016;42:1894–1902.

9Patel N, et al: Influence of electronic and formulation variables on transdermal iontophoresis of tacrine hydrochloride. Pharm Dev Technol 2015;20:442–457.

10Homick JL, et al: Transdermal scopolamine in the prevention of motion sickness: evaluation of the time course of efficacy. Aviat Space Environ Med 1983;54:994–1000.

11Kim YC, et al: Microneedle delivery of trivalent influenza vaccine to the skin induces long-term cross-protection. J Drug Target 2016;24:943–951.

12Jain S, et al: Quality by design approach for formulation, evaluation and statistical optimization of diclofenac-loaded ethosomes via transdermal route. Pharm Dev Technol 2015;20:473–489.

13Barry BW: Drug delivery routes in skin: a novel approach. Adv Drug Deliv Rev 2002;54(suppl 1):S31–S40.

14Pyatski Y, et al: Effects of permeation enhancers on flufenamic acid delivery in ex vivo human skin by confocal Raman microscopy. Int J Pharm 2016;505:319–328.

15Pham QD, et al: Chemical penetration enhancers in stratum corneum – relation between molecular effects and barrier function. J Control Release 2016;232:175–187.

16Southwell D, Barry BW: Penetration enhancers for human skin: mode of action of 2-pyrrolidone and dimethylformamide on partition and diffusion of model compounds water, n-alcohols, and caffeine. J Invest Dermatol 1983;80:507–514.

17Kumar S, et al: Peptides as skin penetration enhancers: mechanisms of action. J Control Release 2015;199:168–78.

18Lu SW, et al: Arginine-rich intracellular delivery peptides synchronously deliver covalently and noncovalently linked proteins into plant cells. J Agric Food Chem 2010;58:2288–2294.

19Venuganti VV, Perumal OP: Effect of poly(amidoamine) (PAMAM) dendrimer on skin permeation of 5-fluorouracil. Int J Pharm 2008;361:230–238.

20Piemi MP, et al: Positively and negatively charged submicron emulsions for enhanced topical delivery of antifungal drugs. J Control Release 1999;58:177–187.

21Lawrence MJ, Rees GD: Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 2000;45:89–121.

22Kumar M, Pathak K, Misra A: Formulation and characterization of nanoemulsion-based drug delivery system of risperidone. Drug Dev Ind Pharm 2009;35:387–395.

23Liu W, et al: Formation and stability of paraffin oil-in-water nano-emulsions prepared by the emulsion inversion point method. J Colloid Interface Sci 2006;303:557–563.

24Paliwal R, Babu RJ, Palakurthi S: Nanomedicine scale-up technologies: feasibilities and challenges. AAPS PharmSciTech 2014;15:1527–1534.

25Jeengar MK, et al: Emu oil based nano-emulgel for topical delivery of curcumin. Int J Pharm 2016;506:222–236.

26Brownlow B, et al: Development and in vitro evaluation of vitamin E-enriched nanoemulsion vehicles loaded with genistein for chemoprevention against uvb-induced skin damage. J Pharm Sci 2015;104:3510–3523.

27Pham J, et al: Enhanced effectiveness of tocotrienol-based nano-emulsified system for topical delivery against skin carcinomas. Drug Deliv 2016;23:1514–1524.

28Dayan N, Touitou E: Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 2000;21:1879–1885.

29Hua S: Lipid-based nano-delivery systems for skin delivery of drugs and bioactives. Front Pharmacol 2015;6:219.

30Iqbal B, Ali J, Baboota S: Recent advances and development in epidermal and dermal drug deposition enhancement technology. Int J Dermatol 2018;57:646–660.

31Mezei M, Gulasekharam V: Liposomes – a selective drug delivery system for the topical route of administration. Lotion dosage form. Life Sci 1980;26:1473–1477.

32Jain S, et al: Recent advances in lipid-based vesicles and particulate carriers for topical and transdermal application. J Pharm Sci 2017;106:423–445.

33Hofland HE, et al: Interactions between liposomes and human stratum corneum in vitro: freeze fracture electron microscopical visualization and small angle X-ray scattering studies. Br J Dermatol 1995;132:853–866.

34Elsayed MM, et al: Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm 2007;332:1–16.

35Kitagawa S, Kasamaki M: Enhanced delivery of retinoic acid to skin by cationic liposomes. Chem Pharm Bull 2006;54:242–244.

36Gershkovich P, Wasan KM, Barta CA: A review of the application of lipid-based systems in systemic, dermal/transdermal, and ocular drug delivery. Crit Rev Ther Drug Carrier Syst 2008;25:545–584.

37Chen J, et al: Skin permeation behavior of elastic liposomes: role of formulation ingredients. Expert Opin Drug Deliv 2013;10:845–856.

38Cevc G, Blume G: Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1992;1104:226–232.

39Rajan R, et al: Transferosomes – a vesicular transdermal delivery system for enhanced drug permeation. J Adv Pharm Technol Res 2011;2:138–143.

40Godin B, Touitou E: Ethosomes: new prospects in transdermal delivery. Crit Rev Ther Drug Carrier Syst 2003;20:63–102.

41Verma P, Pathak K: Therapeutic and cosmeceutical potential of ethosomes: an overview. J Adv Pharm Technol Res 2010;1:274–282.

42Paolino D, et al: Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Control Release 2005;106:99–110.

43Kasetvatin C, Rujivipat S, Tiyaboonchai W: Combination of elastic liposomes and low frequency ultrasound for skin permeation enhancement of hyaluronic acid. Colloids Surf B Biointerfaces 2015;135:458–464.

44Mura S, et al: Liposomes and niosomes as potential carriers for dermal delivery of minoxidil. J Drug Target 2007;15:101–108.

45Tavano L, et al: Co-encapsulation of lipophilic antioxidants into niosomal carriers: percutaneous permeation studies for cosmeceutical applications. Colloids Surf B Biointerfaces 2014;114:144–149.

46Hougeir FG, Kircik L: A review of delivery systems in cosmetics. Dermatol Ther 2012;25:234–237.

47Mukherjee S, Ray S, Thakur RS: Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci 2009;71:349–358.

48Vettor M, et al: Poly(D,L-lactide) nanoencapsulation to reduce photoinactivation of a sunscreen agent. Int J Cosmet Sci 2008;30:219–227.

49Kaity S, et al: Microsponges: a novel strategy for drug delivery system. J Adv Pharm Technol Res 2010;1:283–290.

50Embil K, Nacht S: The microsponge delivery system (MDS): a topical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives. J Microencapsul 1996;13:575–588.

51Gangadharappa HV, et al: Current trends in microsponge drug delivery system. Curr Drug Deliv 2013;10:453–465.

52Cooper DL, Conder CM, Harirforoosh S: Nanoparticles in drug delivery: mechanism of action, formulation and clinical application towards reduction in drug-associated nephrotoxicity. Expert Opin Drug Deliv 2014;11:1661–1680.

53Moinard-Checot D, et al: Nanoparticles for drug delivery: review of the formulation and process difficulties illustrated by the emulsion-diffusion process. J Nanosci Nanotechnol 2006;6:2664–2681.

54Muller RH, Mader K, Gohla S: Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm 2000;50:161–177.

55Mehnert W, Mader K: Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 2001;47:165–196.

56Trombino S, et al: Stearyl ferulate-based solid lipid nanoparticles for the encapsulation and stabilization of beta-carotene and alpha-tocopherol. Colloids Surf B Biointerfaces 2009;72:181–187.

57Souto EB, Muller RH, Gohla S: A novel approach based on lipid nanoparticles (SLN) for topical delivery of alpha-lipoic acid. J Microencapsul 2005;22:581–592.

58Souto EB, et al: Preparation and characterization of <italic>n</italic>-dodecyl-ferulate-loaded solid lipid nanoparticles (SLN). Int J Pharm 2005;295:261–268.

59Jee JP, et al: Stabilization of all-trans retinol by loading lipophilic antioxidants in solid lipid nanoparticles. Eur J Pharm Biopharm 2006;63:134–139.

60Bhagurkar AM, Repka MA, Murthy SN: A novel approach for the development of a nanostructured lipid carrier formulation by hot-melt extrusion technology. J Pharm Sci 2017;106:1085–1091.

61Fang CL, Al-Suwayeh SA, Fang JY: Nanostructured lipid carriers (NLCs) for drug delivery and targeting. Recent Pat Nanotechnol 2013;7:41–55.

62Li B, Ge ZQ: Nanostructured lipid carriers improve skin permeation and chemical stability of idebenone. AAPS PharmSciTech 2012;13:276–283.

63Uprit S, et al: Preparation and characterization of minoxidil loaded nanostructured lipid carrier gel for effective treatment of alopecia. Saudi Pharm J 2013;21:379–385.

64Kawadkar J, et al: Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery. Drug Dev Ind Pharm 2013;39:569–578.

65Wang J, et al: Physicochemical characterization, identification and improved photo-stability of alpha-lipoic acid-loaded nanostructured lipid carrier. Drug Dev Ind Pharm 2014;40:201–210.

Rawaa M. Almukhtar

Cosmetic Laser Dermatology

9339 Genesee Ave, Suite 300

San Diego, CA 92121 (USA)

ralmukhtar@clderm.com